Kungsbacka, Sweden

Marianne Frantsi

This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2001-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marianne Frantsi. Retrieved from https://idiyas.com/inventor/marianne-frantsi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Marianne Frantsi

Introduction

Marianne Frantsi is a notable inventor based in Kungsbacka, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiarrhythmic compounds. With a total of 2 patents to her name, her work has the potential to impact the treatment of cardiac arrhythmias.

Latest Patents

Frantsi's latest patents include "Bispidine compounds useful in the treatment of cardiac arrhythmias" and "Bispidine antiarrhythmic compounds." These innovations focus on compounds that can provide effective treatment options for patients suffering from heart rhythm disorders.

Career Highlights

Marianne Frantsi is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her role at AstraZeneca has allowed her to engage in cutting-edge research and development, contributing to advancements in medical science.

Collaborations

Throughout her career, Frantsi has collaborated with esteemed colleagues such as Kurt-Jürgen Hoffmann and Gert Strandlund. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Marianne Frantsi's contributions to the field of pharmaceuticals exemplify the impact of dedicated inventors in advancing medical treatments. Her work continues to pave the way for new solutions in cardiac care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…